Ready for Change: Enhancing Motivational Engagement Prior to IIPT (PREPaRe)

October 9, 2023 updated by: Deirdre Logan, Boston Children's Hospital

Ready for Change: A Telehealth, Motivational Enhancement Pre-habilitation Training to Increase Engagement in Children and Families Entering Intensive Interdisciplinary Pain Rehabilitation

This is a randomized, motivational-interviewing-based intervention to improve readiness-to-change, or willingness to engage in a self-management approach to chronic pain, for patients referred to our intensive interdisciplinary pain rehabilitation day program.

Study Overview

Status

Enrolling by invitation

Conditions

Detailed Description

Readiness to change, or willingness to engage in a self-management approach to chronic pain and disability, is the most powerful predictor of children's success in intensive pediatric pain rehabilitation. Motivational Enhancement Therapy (MET) is an approach that has been effective in increasing readiness to change and treatment engagement for other behaviorally-oriented health interventions. However, MET has never been systemically employed in the context of treating pediatric chronic pain and disability.

This demonstration project seeks to test the effects of a novel telehealth intervention using motivation enhancement therapy to improve patient and parent engagement in, and outcomes of, an intensive interdisciplinary day hospital program for children with complex chronic pain conditions and associated disability, the Pediatric Pain Rehabilitation Center (PPRC). The intervention, PPRC-Prep, is a 4 week MET-based telehealth intervention that will be offered to families of children with refractory chronic pain conditions awaiting admission to the PPRC at Boston Children's Hospital at Waltham. Families approved for and awaiting PPRC admission will be randomized to receive PPRC-Prep along with usual care or to a comparison group receiving treatment as usual. Study aims include assessing the feasibility and acceptability of the intervention along with measuring its potential to increase readiness to engage in a self-management approach assessed at time of admission to the PPRC using established measures of readiness to change, pain acceptance, and committed action. Investigators will also evaluate the effects of PPRC-Prep on program length of stay and on reductions of disability and pain at PPRC discharge and short-term (8-week) follow up through comparison of families who undergo PPRC-prep with families who do not undergo PPRC-prep. Demonstrating the feasibility and preliminary effectiveness of PPRC-Prep will enable the study team to establish this as a routine component of our approach to care for children with complex, refractory chronic pain and disability.

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02115
        • Boston Children's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patient age 8-18 at enrollment
  • Presence of chronic pain condition for > 3 months with moderate or severe disability
  • Accepts referral to PPRC and awaiting admission

Exclusion Criteria:

  • Non-English speaking
  • No access to device with telehealth capability

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Receive motivational enhancement training based, telehealth-delivered 6-8 session intervention aimed at increasing readiness to engage in pain self-management, in addition to all recommended outpatient treatments.
see previous
To include all recommended outpatient treatments
Active Comparator: Standard Care
Participate in all recommended outpatient pain treatments while awaiting PPRC admission.
To include all recommended outpatient treatments

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of stay
Time Frame: PPRC discharge [within 6 months of baseline]
length of stay in PPRC program (in days)
PPRC discharge [within 6 months of baseline]
Functional disability inventory (FDI) total score
Time Frame: at PPRC discharge [within 6 months of baseline]
level of pain related functional disability, ranges from 0-60 with higher scores indicating more disability
at PPRC discharge [within 6 months of baseline]
Functional disability inventory (FDI) total score
Time Frame: at PPRC follow up (4-8 weeks post discharge)
level of pain related functional disability, ranges from 0-60 with higher scores indicating more disability
at PPRC follow up (4-8 weeks post discharge)
Functional disability inventory (FDI) total score
Time Frame: at PPRC follow up (1 year post discharge)
level of pain related functional disability, ranges from 0-60 with higher scores indicating more disability
at PPRC follow up (1 year post discharge)
Pain stages of change questionnaire for adolescents (PSOCQ-A)
Time Frame: PPRC admission (within 2 months of baseline)
readiness to change/embrace pain self-management. 13 item scale with total scores ranging from 13-65. Domain with highest score is considered current stage of change.
PPRC admission (within 2 months of baseline)
Pain stages of change questionnaire for adolescents (PSOCQ-A)
Time Frame: PPRC discharge [within 6 months of baseline]
readiness to change/embrace pain self-management. 13 item scale with total scores ranging from 13-65. Domain with highest score is considered current stage of change.
PPRC discharge [within 6 months of baseline]
Pain stages of change questionnaire for adolescents (PSOCQ-A)
Time Frame: at PPRC follow up (4-8 weeks post discharge)
readiness to change/embrace pain self-management. 13 item scale with total scores ranging from 13-65. Domain with highest score is considered current stage of change.
at PPRC follow up (4-8 weeks post discharge)
Pain stages of change questionnaire for adolescents (PSOCQ-A)
Time Frame: at PPRC follow up (1 year post discharge)
readiness to change/embrace pain self-management. 13 item scale with total scores ranging from 13-65. Domain with highest score is considered current stage of change.
at PPRC follow up (1 year post discharge)
Modified Adolescent Treatment Engagement Questionnaire
Time Frame: At end of intervention, 4 weeks from baseline
Level of engagement in treatment. Scores 0-40 higher scores indicate more engagement.
At end of intervention, 4 weeks from baseline
Treatment satisfaction inventory
Time Frame: At end of intervention, 4 weeks from baseline
Participant satisfaction with treatment. 13 items range 13-65, higher scores = more satisfaction
At end of intervention, 4 weeks from baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain intensity
Time Frame: At PPRC admission (4-6 weeks post baseline)
pain intensity on 0-10 numeric scale (10=worst pain)
At PPRC admission (4-6 weeks post baseline)
Pain intensity
Time Frame: At PPRC discharge [within 6 months of baseline]
pain intensity on 0-10 numeric scale (10=worst pain)
At PPRC discharge [within 6 months of baseline]
Pain intensity
Time Frame: At first post-treatment follow up (4-8 weeks post discharge)
pain intensity on 0-10 numeric scale (10=worst pain)
At first post-treatment follow up (4-8 weeks post discharge)
Pain intensity
Time Frame: 1 year post-treatment
pain intensity on 0-10 numeric scale (10=worst pain)
1 year post-treatment
Chronic Pain Acceptance Questionnaire total score
Time Frame: At PPRC admission [typically within 3 months of baseline]
Secondary measure of readiness to change/engage in pain self-management. 20 item questionnaire, will use total score. Range 0-120. HIgher scores indicate more pain acceptance.
At PPRC admission [typically within 3 months of baseline]
Chronic Pain Acceptance Questionnaire total score
Time Frame: At PPRC discharge [within 6 months of baseline]
Secondary measure of readiness to change/engage in pain self-management. 20 item questionnaire, will use total score. Range 0-120. HIgher scores indicate more pain acceptance.
At PPRC discharge [within 6 months of baseline]
Committed action questionnaire total score
Time Frame: At PPRC admission [typically within 3 months of baseline]
Secondary measure of readiness to change/engage in pain self-management. 8 item questionnaire with range 0-48. Higher scores indicate more committed action.
At PPRC admission [typically within 3 months of baseline]
Committed action questionnaire
Time Frame: At PPRC discharge [within 6 months of baseline]
Secondary measure of readiness to change/engage in pain self-management. 8 item questionnaire with range 0-48. Higher scores indicate more committed action/readiness.
At PPRC discharge [within 6 months of baseline]

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 15, 2020

Primary Completion (Estimated)

December 1, 2023

Study Completion (Estimated)

December 1, 2023

Study Registration Dates

First Submitted

September 10, 2019

First Submitted That Met QC Criteria

September 16, 2019

First Posted (Actual)

September 18, 2019

Study Record Updates

Last Update Posted (Actual)

October 11, 2023

Last Update Submitted That Met QC Criteria

October 9, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • P00033150

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

This is a pilot study and we do not think the data should be shared.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Pain

Clinical Trials on MET-based therapy

3
Subscribe